KA501: pMVP (L3-L2) pA; CMV::TETa-pA
PurposepMVP L3-L2 entry plasmid, contains polyA + CMV-TETa-polyA for 3- or 4-component MultiSite Gateway Pro assembly. Adds CMV-driven TETa downstream of gene of interest.
|Item||Catalog #||Description||Quantity||Price (USD)|
|Plasmid||121801||Standard format: Plasmid sent in bacteria as agar stab||1||$65|
This material is available to academics and nonprofits only.
Vector backbonepDONR221 P3-P2
- Backbone size w/o insert (bp) 2555
Vector typeSynthetic Biology ; pMVP Gateway Entry Plasmid
Growth in Bacteria
Copy numberHigh Copy
Gene/Insert namepolyA + CMV::TETa-polyA
Insert Size (bp)2116
- Cloning method Gateway Cloning
- 5′ sequencing primer M13F
- 3′ sequencing primer M13R (Common Sequencing Primers)
TETa sequence derived from Tet-On Advanced system (Clontech)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
For your Materials & Methods section:KA501: pMVP (L3-L2) pA; CMV::TETa-pA was a gift from Christopher Newgard (Addgene plasmid # 121801 ; http://n2t.net/addgene:121801 ; RRID:Addgene_121801)
For your References section:Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing. Haldeman JM, Conway AE, Arlotto ME, Slentz DH, Muoio DM, Becker TC, Newgard CB. Nucleic Acids Res. 2018 Dec 27. pii: 5264291. doi: 10.1093/nar/gky1286. 10.1093/nar/gky1286 PubMed 30590691